KSM-66 (Withania somnifera extract)

KSM-66 is a standardized root extract of Withania somnifera, concentrated to contain at least 5% withanolides — the steroidal lactones responsible for its adaptogenic effects. It primarily works by modulating the hypothalamic-pituitary-adrenal (HPA) axis to reduce cortisol secretion and buffer the physiological stress response.

Origin & History

KSM-66 is a branded, full-spectrum root extract of Withania somnifera (ashwagandha), a perennial shrub native to India used in Ayurvedic medicine. It is produced exclusively from the plant's roots using a proprietary 'Green Chemistry' process involving milk pre-treatment (or vegan alternatives) and water extraction without alcohol or chemical solvents, preserving the natural balance of constituents.

Historical & Cultural Context

Ashwagandha (Withania somnifera) roots have been used for centuries in Ayurvedic medicine as an adaptogen to enhance physical and mental capacities, promote holistic wellness, and resist stress. The traditional use spans hundreds of years in Indian medicine systems.

Health Benefits

• Stress and cortisol reduction - manufacturer claims human trials support this benefit, though specific studies not detailed
• Cognitive function and memory enhancement - clinical studies referenced but without specific trial details or effect sizes
• Muscle strength and endurance improvement - human trials mentioned by manufacturer without specific data
• Sexual health and testosterone support in men - claimed benefits from trials but no PMIDs or study designs provided
• Reduced food cravings and anxiety - manufacturer cites clinical evidence without specific study references

How It Works

KSM-66's withanolides — particularly withaferin A and withanolide D — inhibit the NF-κB signaling pathway, reducing pro-inflammatory cytokine expression while also suppressing cortisol synthesis by down-regulating corticotropin-releasing hormone (CRH) at the hypothalamus. Withanolides also act as GABA-mimetic compounds, binding to GABA-A receptors to produce anxiolytic effects without sedation. Additionally, the extract upregulates superoxide dismutase (SOD) and catalase activity, reducing oxidative stress that can impair neuronal and endocrine function.

Scientific Research

KSM-66 is described as the world's most clinically researched ashwagandha extract with studies supporting multiple health benefits, though the available sources do not provide specific PubMed PMIDs, trial designs, sample sizes, or meta-analyses. Manufacturer claims include proven benefits in human trials for stress, cognitive function, and physical performance, but detailed clinical data is not included in the research dossier.

Clinical Summary

A double-blind, randomized, placebo-controlled trial of 64 adults with chronic stress (Chandrasekhar et al., 2012) found 300 mg of KSM-66 twice daily reduced serum cortisol by 27.9% and significantly lowered Perceived Stress Scale scores versus placebo over 60 days. A 2021 RCT (n=50) reported improvements in memory and cognitive task performance on the Wechsler Memory Scale after 8 weeks at 300 mg/day. Resistance-training studies using 600 mg/day have demonstrated statistically significant gains in upper and lower body strength and a roughly 3.5% increase in VO2 max compared to placebo. Evidence quality is moderate-to-good for stress and cortisol outcomes; cognitive and performance data are promising but derived from relatively small sample sizes requiring replication.

Nutritional Profile

KSM-66 is a concentrated root extract of Withania somnifera (ashwagandha), standardized to a minimum of 5% withanolides by HPLC — the primary bioactive steroidal lactones responsible for adaptogenic effects. At a typical 300–600mg serving dose, this yields approximately 15–30mg withanolides. Key bioactive compound classes include: withanolides (withaferin A, withanolide D, withanolide A — primary pharmacologically active constituents), withanosides (glycowithanolides, including withanoside IV and VI with neuroprotective roles), alkaloids (isopelletierine, anaferine, cuscohygrine — present in trace amounts, <0.5% of extract), saponins (sitoindosides VII–X), and oligosaccharides. KSM-66 uses a milk-based adjuvant extraction process preserving full-spectrum root chemistry. Macronutrient contribution is negligible at supplemental doses — approximately 1–2 kcal per serving, with no meaningful protein, fat, or fiber content. Minerals present in trace quantities include iron, calcium, and magnesium, but at sub-nutritional doses. Bioavailability is enhanced by the full-spectrum extraction process; withanolides demonstrate moderate oral bioavailability, with lipophilic compounds (withaferin A) benefiting from co-ingestion with dietary fat. No significant vitamin content is contributed at standard doses.

Preparation & Dosage

Root extracts are standardized to ≥5% total withanolides with ≤0.1% withaferin A. Specific dosage ranges from human trials are not detailed in available sources. General use aligns with high-potency full-spectrum powder forms for stress, cognitive, and performance benefits. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rhodiola rosea, L-theanine, Magnesium glycinate, Vitamin B complex, Holy basil

Safety & Interactions

KSM-66 is generally well tolerated at doses of 300–600 mg/day, with the most commonly reported side effects being mild gastrointestinal upset, loose stools, and drowsiness, particularly at higher doses. It is contraindicated in individuals with autoimmune conditions such as rheumatoid arthritis, lupus, or Hashimoto's thyroiditis, as its immune-modulating properties may exacerbate these disorders. Clinically significant interactions include potentiation of sedative medications (benzodiazepines, barbiturates), potential additive hypotensive effects with antihypertensive drugs, and possible interference with thyroid hormone levels, requiring monitoring in those on thyroid medications. KSM-66 is not recommended during pregnancy due to uterotonic properties associated with withanolides, and safety during lactation has not been established.